Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
DeliriumAgitation
Interventions
DRUG

Dexmedetomidine

dexmedetomidine infusion titrated to effect

OTHER

Standard of Care

Standard of care per treating physician preference

Trial Locations (1)

02118

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT00351299 - Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium | Biotech Hunter | Biotech Hunter